QRX003 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-01-31 in 4mo
ESTIMATED |
READOUT
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/3 · Netherton Syndrome |
QNRX Quoin Pharmaceuticals Ltd. | QRX003 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
|